A randomized, open label, phase 1b study to evaluate safety, PK and PD signals of DUR-928 in patients with Non-Alcoholic Steatohepatitis (NASH)
Research Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
High Point Clinical Trial Center
Start Date
May 3, 2019
End Date
May 2, 2020
Administered By
Radiology, Abdominal Imaging
Awarded By
High Point Clinical Trial Center
Start Date
May 3, 2019
End Date
May 2, 2020